Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonoscopy | 4 | 2021 | 53 | 0.530 |
Why?
|
| Intestinal Mucosa | 4 | 2018 | 232 | 0.470 |
Why?
|
| Colonic Polyps | 2 | 2018 | 26 | 0.430 |
Why?
|
| Granular Cell Tumor | 1 | 2007 | 5 | 0.290 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 74 | 0.280 |
Why?
|
| HIV Infections | 4 | 2018 | 890 | 0.260 |
Why?
|
| Hernia, Diaphragmatic, Traumatic | 1 | 2003 | 1 | 0.220 |
Why?
|
| Colon | 3 | 2018 | 163 | 0.200 |
Why?
|
| Laparoscopy | 1 | 2003 | 171 | 0.190 |
Why?
|
| Gene Expression Profiling | 3 | 2018 | 164 | 0.190 |
Why?
|
| Adenoma | 1 | 2021 | 46 | 0.180 |
Why?
|
| Biopsy | 5 | 2021 | 249 | 0.160 |
Why?
|
| Microbiota | 2 | 2017 | 130 | 0.160 |
Why?
|
| Interferon Type I | 1 | 2018 | 22 | 0.160 |
Why?
|
| Immunologic Factors | 1 | 2018 | 42 | 0.150 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2017 | 64 | 0.150 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2017 | 19 | 0.150 |
Why?
|
| Cytomegalovirus Infections | 1 | 2017 | 83 | 0.140 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 284 | 0.130 |
Why?
|
| Immunity, Mucosal | 1 | 2015 | 32 | 0.120 |
Why?
|
| Hepatitis B Vaccines | 1 | 2014 | 8 | 0.120 |
Why?
|
| Hepatitis B | 1 | 2014 | 20 | 0.120 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2017 | 211 | 0.120 |
Why?
|
| Vaccination | 1 | 2014 | 48 | 0.120 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 89 | 0.120 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 91 | 0.120 |
Why?
|
| Patient Compliance | 1 | 2015 | 158 | 0.110 |
Why?
|
| Middle Aged | 8 | 2018 | 10192 | 0.110 |
Why?
|
| Mass Screening | 1 | 2015 | 186 | 0.110 |
Why?
|
| Male | 10 | 2018 | 16425 | 0.110 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2014 | 90 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2014 | 135 | 0.110 |
Why?
|
| Capsule Endoscopy | 1 | 2012 | 3 | 0.110 |
Why?
|
| Gastrointestinal Transit | 1 | 2012 | 11 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2012 | 34 | 0.100 |
Why?
|
| Humans | 13 | 2021 | 30959 | 0.100 |
Why?
|
| Female | 9 | 2018 | 16965 | 0.070 |
Why?
|
| Adult | 6 | 2018 | 8924 | 0.070 |
Why?
|
| Ileum | 2 | 2017 | 25 | 0.070 |
Why?
|
| Recurrence | 2 | 2003 | 369 | 0.060 |
Why?
|
| Endoscopy, Digestive System | 1 | 2003 | 9 | 0.060 |
Why?
|
| Esophagitis | 1 | 2003 | 11 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2018 | 3806 | 0.060 |
Why?
|
| Eosinophilia | 1 | 2003 | 50 | 0.050 |
Why?
|
| Heartburn | 1 | 2003 | 1 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 1009 | 0.050 |
Why?
|
| Hernia, Hiatal | 1 | 2003 | 11 | 0.050 |
Why?
|
| Thoracotomy | 1 | 2003 | 25 | 0.050 |
Why?
|
| Fundoplication | 1 | 2003 | 20 | 0.050 |
Why?
|
| Safety | 1 | 2003 | 49 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2003 | 24 | 0.050 |
Why?
|
| Aged | 4 | 2015 | 10047 | 0.050 |
Why?
|
| Esophageal Diseases | 1 | 2002 | 5 | 0.050 |
Why?
|
| Leukemia, Myeloid | 1 | 2002 | 6 | 0.050 |
Why?
|
| Aspergillus fumigatus | 1 | 2002 | 4 | 0.050 |
Why?
|
| Endocarditis | 1 | 2002 | 10 | 0.050 |
Why?
|
| Logistic Models | 2 | 2015 | 409 | 0.050 |
Why?
|
| Aspergillosis | 1 | 2002 | 12 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2003 | 144 | 0.050 |
Why?
|
| Observer Variation | 1 | 2021 | 118 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2003 | 532 | 0.050 |
Why?
|
| Proof of Concept Study | 1 | 2018 | 14 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 817 | 0.040 |
Why?
|
| Reoperation | 1 | 2003 | 950 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2018 | 99 | 0.040 |
Why?
|
| DNA, Ribosomal | 1 | 2017 | 13 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 53 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 80 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2017 | 97 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 166 | 0.040 |
Why?
|
| Viral Load | 1 | 2017 | 196 | 0.040 |
Why?
|
| Biomarkers | 2 | 2014 | 733 | 0.030 |
Why?
|
| Cytokines | 1 | 2017 | 351 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2014 | 11 | 0.030 |
Why?
|
| Serologic Tests | 1 | 2014 | 16 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 147 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 322 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 74 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2014 | 3658 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 80 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 44 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2014 | 91 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 158 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 156 | 0.030 |
Why?
|
| Sex Factors | 1 | 2015 | 510 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 549 | 0.030 |
Why?
|
| Prevalence | 1 | 2014 | 500 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2012 | 26 | 0.030 |
Why?
|
| Age Factors | 1 | 2015 | 872 | 0.030 |
Why?
|
| Adolescent | 2 | 2012 | 2399 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 2060 | 0.020 |
Why?
|
| Risk Factors | 2 | 2012 | 2586 | 0.020 |
Why?
|
| Chicago | 1 | 2014 | 943 | 0.020 |
Why?
|
| Inpatients | 1 | 2012 | 150 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 2042 | 0.020 |
Why?
|
| United States | 1 | 2015 | 2373 | 0.020 |
Why?
|
| Histamine H1 Antagonists | 1 | 2003 | 5 | 0.010 |
Why?
|
| Budesonide | 1 | 2003 | 5 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 2003 | 7 | 0.010 |
Why?
|
| Histamine H2 Antagonists | 1 | 2003 | 7 | 0.010 |
Why?
|
| Azathioprine | 1 | 2003 | 9 | 0.010 |
Why?
|
| Esophageal Perforation | 1 | 2003 | 8 | 0.010 |
Why?
|
| Gastric Mucosa | 1 | 2003 | 14 | 0.010 |
Why?
|
| Proton Pump Inhibitors | 1 | 2003 | 13 | 0.010 |
Why?
|
| Gastrointestinal Motility | 1 | 2003 | 14 | 0.010 |
Why?
|
| Proton Pumps | 1 | 2003 | 14 | 0.010 |
Why?
|
| Catheterization | 1 | 2003 | 51 | 0.010 |
Why?
|
| Deglutition Disorders | 1 | 2003 | 45 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 2003 | 34 | 0.010 |
Why?
|
| Prednisone | 1 | 2003 | 69 | 0.010 |
Why?
|
| Eosinophils | 1 | 2003 | 49 | 0.010 |
Why?
|
| Esophagus | 1 | 2003 | 74 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2003 | 103 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 138 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 5189 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 407 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 231 | 0.010 |
Why?
|
| Autopsy | 1 | 2002 | 351 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 817 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2003 | 1922 | 0.010 |
Why?
|